On 2025-08-14, Unicycive Therapeutics, Inc. (UNCY) announced earnings per share of $-0.52 for the fiscal quarter ending 2025-06-30, beating the average analyst estimate of $-0.70.
The next expected annoucement date for quarterly earnings is 2025-11-12, with an average estimated earnings per share of $-0.60 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-14 | 2025-06-30 | $-0.70 | $-0.52 |
| 2025-05-14 | 2025-03-31 | $-0.80 | $-0.50 |
| 2025-03-31 | 2024-12-31 | $-1.30 | $-2.60 |
| 2024-11-13 | 2024-09-30 | $-1.30 | $-0.50 |
| 2024-08-14 | 2024-06-30 | $-2.30 | $-1.50 |
| 2024-05-13 | 2024-03-31 | $-1.80 | $-2.70 |
| 2024-03-28 | 2023-12-31 | $-1.80 | $-1.60 |
| 2023-11-14 | 2023-09-30 | $-1.30 | $-1.30 |
| 2023-08-14 | 2023-06-30 | $-3.90 | $-2.90 |
| 2023-05-16 | 2023-03-31 | $-3.60 | $-2.90 |
| 2023-03-31 | 2022-12-31 | -- | $-3.50 |
| 2022-11-14 | 2022-09-30 | $-3.50 | $-3.70 |
| 2022-08-15 | 2022-06-30 | $-2.70 | $-2.40 |
| 2022-05-12 | 2022-03-31 | $-2.00 | $-2.40 |
| 2022-03-31 | 2021-12-31 | -- | $-1.70 |
| 2021-11-11 | 2021-09-30 | $-1.10 | $-3.70 |
| 2021-08-16 | 2021-06-30 | $-1.10 | $-1.30 |